data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Edap TMS

(NASDAQ:EDAP)

Intraday

$7.26

0.11[1.54%]

After-Hours

$7.26

0[0.00%]

Perks Buy Compare Brokers

$7.26

0.11[1.54%]

At close: Apr 19

$7.26

0[0.00%]

PreMarket: 4:00PM EDT

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Edap TMS Stock (NASDAQ:EDAP)

Edap TMS Stock (NASDAQ: EDAP)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, April 05, 2024

EDAP TMS SA Files For Mixed Shelf Of Up To $125M
Benzinga Newsdesk - Apr 5, 2024, 4:37PM

Monday, April 01, 2024

HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $19
Benzinga Newsdesk - Apr 1, 2024, 6:58AM

Wednesday, March 27, 2024

Edap TMS Q4 EPS $(0.15) Misses $(0.05) Estimate, Sales $21.30M Beat $19.66M Estimate
Benzinga Newsdesk - Mar 27, 2024, 7:02AM
Earnings Scheduled For March 27, 2024
Benzinga Insights - Mar 27, 2024, 5:02AM

Tuesday, March 26, 2024

Earnings Outlook For Edap TMS
Benzinga Insights - Mar 26, 2024, 11:01AM

Monday, March 04, 2024

EDAP Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis
Benzinga Newsdesk - Mar 4, 2024, 7:02AM

Thursday, February 29, 2024

EDAP TMS Reports Preliminary FY2023 Revenues Of €60.4M (Around $65.4M) Versus Consensus Of €58.151M And Q4 FY2023 Revenues Of €19.6M (Around $21.3M) Versus Consensus Of €17.232M
Benzinga Newsdesk - Feb 29, 2024, 7:41AM

Thursday, February 01, 2024

EDAP Announces Completion Of Enrollment In Phase 3 Study Evaluating Focal One HIFU Therapy For Deep Infiltrating Rectal Endometriosis
Benzinga Newsdesk - Feb 1, 2024, 8:10AM

Monday, January 08, 2024

EDAP Announces Preliminary Q4 Record Focal One System Sales And Placements; Company Reports Preliminary Placement Results Of Twelve Focal One Systems, Inclusive Of Ten Capital Sales
Benzinga Newsdesk - Jan 8, 2024, 8:32AM

Tuesday, January 02, 2024

EDAP Appoints Ken Mobeck As Global Chief Financial Officer
Benzinga Newsdesk - Jan 2, 2024, 8:10AM

Tuesday, December 12, 2023

EDAP Announces Positive Opinion For Reimbursement From The French National Authority For Health For HIFU Treatment Of Prostate Cancer
Benzinga Newsdesk - Dec 12, 2023, 8:06AM

Friday, November 10, 2023

Piper Sandler Maintains Overweight on Edap TMS, Lowers Price Target to $9-Report released on 9th Nov 2023
Benzinga Newsdesk - Nov 10, 2023, 5:18PM

Thursday, November 09, 2023

EDAP TMS shares are trading lower after the company reported worse-than-expected Q3 revenue results.
Benzinga Newsdesk - Nov 9, 2023, 1:29PM
Earnings Scheduled For November 9, 2023
Benzinga Insights - Nov 9, 2023, 6:52AM
Edap TMS Q3 EPS $(0.11), Inline, Sales $12.69M Miss $16.21M Estimate
Benzinga Newsdesk - Nov 9, 2023, 6:15AM
Recap: Edap TMS Q3 Earnings
Benzinga Insights - Nov 9, 2023, 6:10AM

Thursday, November 02, 2023

Vuzix Announces Partnership With EDAP TMS To Supply Smart Glasses For Its Focal One Robotic High Intensity Focused Ultrasound Platform
Benzinga Newsdesk - Nov 2, 2023, 3:59PM

Thursday, September 07, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Sep 7, 2023, 1:55PM

Wednesday, September 06, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Sep 6, 2023, 2:43PM

Friday, August 25, 2023

HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $16 Price Target
Benzinga Newsdesk - Aug 25, 2023, 6:05AM

Thursday, August 24, 2023

Edap TMS Q2 EPS $(0.14) Misses $(0.05) Estimate, Sales $15.52M Miss $16.73M Estimate
Benzinga Newsdesk - Aug 24, 2023, 6:33AM
Earnings Scheduled For August 24, 2023
Benzinga Insights - Aug 24, 2023, 4:21AM

Wednesday, August 23, 2023

Edap TMS's Earnings Outlook
Benzinga Insights - Aug 23, 2023, 12:00PM

Wednesday, July 26, 2023

EDAP TMS Announces Reimbursement Approval In Switzerland For The Use Of High-Intensity Focused Ultrasound In The Treatment Of Prostate Cancer
Benzinga Newsdesk - Jul 26, 2023, 8:19AM

Thursday, May 18, 2023

Lake Street Maintains Buy on Edap TMS, Raises Price Target to $16
Benzinga Newsdesk - May 18, 2023, 9:29AM

Wednesday, May 17, 2023

Earnings Scheduled For May 17, 2023
Benzinga Insights - May 17, 2023, 8:06AM
Recap: Edap TMS Q1 Earnings
Benzinga Insights - May 17, 2023, 6:45AM
Edap TMS Q1 EPS $(0.22) Misses $(0.03) Estimate, Sales $15.95M Beat $14.91M Estimate
Benzinga Newsdesk - May 17, 2023, 6:35AM

Tuesday, May 16, 2023

Edap TMS Earnings Preview
Benzinga Insights - May 16, 2023, 11:03AM

Thursday, April 13, 2023

HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $16
Benzinga Newsdesk - Apr 13, 2023, 6:12AM

Thursday, April 06, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Apr 6, 2023, 9:06AM
EDAP shares were trading higher after the company announced regulatory clearance of ExactVu Micro-Ultrasound in Japan.
Benzinga Newsdesk - Apr 6, 2023, 8:40AM
EDAP TMS Reports Regulatory Clearance Of ExactVu Micro-Ultrasound In Japan
Benzinga Newsdesk - Apr 6, 2023, 8:01AM

Thursday, March 30, 2023

Earnings Scheduled For March 30, 2023
Benzinga Insights - Mar 30, 2023, 7:24AM
EDAP Names Ryan Rhodes As CEO, Effective May 1, 2023
Benzinga Newsdesk - Mar 30, 2023, 6:33AM
Edap TMS Q4 EPS $(0.14) Misses $(0.01) Estimate, Sales $16.19M Miss $17.04M Estimate
Benzinga Newsdesk - Mar 30, 2023, 6:31AM

Wednesday, March 29, 2023

Edap TMS's Earnings: A Preview
Benzinga Insights - Mar 29, 2023, 11:02AM

Wednesday, February 15, 2023

HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $13
Benzinga Newsdesk - Feb 15, 2023, 6:08AM

Tuesday, February 14, 2023

EDAP Sees Prelim. FY22 Total Revenue $58M, Up 25.1% YoY
Bill Haddad - Feb 14, 2023, 9:01AM

Tuesday, January 31, 2023

EDAP Announces Results From Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound In Rectal Endometriosis; Reports 96.7% Of Patients With No Or Non-Significant Adverse Events
Bill Haddad - Jan 31, 2023, 8:08AM
EDAP Announces Phase 2 Trial Results Of High-Intensity Focused Ultrasound (HIFU) For Rectal Endometriosis Showing Significant Improvements In Symptoms And Quality Of Life, With Favorable Safety Profile
Benzinga Newsdesk - Jan 31, 2023, 8:07AM

Tuesday, December 06, 2022

EDAP Appoints Ken Mobeck As Chief Financial Officer Of Company's U.S. Subsidiary
Benzinga Newsdesk - Dec 6, 2022, 8:16AM

Wednesday, November 30, 2022

EDAP Announces Approval To Initiate Randomized Clinical Trial Evaluating Focal One As Potential Treatment For Rectal Deep Infiltrating Endometriosis
Michael Horton - Nov 30, 2022, 4:07PM

Friday, November 18, 2022

Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Lisa Levin - Nov 18, 2022, 7:57AM
HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $12
Benzinga Newsdesk - Nov 18, 2022, 6:22AM

Wednesday, November 16, 2022

Edap TMS Q3 Sales $12.30M Beat $12.17M Estimate
Benzinga Newsdesk - Nov 16, 2022, 4:38PM
Earnings Scheduled For November 16, 2022
Benzinga Insights - Nov 16, 2022, 5:02AM

Tuesday, November 15, 2022

Earnings Outlook For Edap TMS
Benzinga Insights - Nov 15, 2022, 11:28AM

Wednesday, November 02, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Nov 2, 2022, 8:20AM

Tuesday, November 01, 2022

EDAP Announces Focal One HIFU Reimbursement Raised To Urology APC Level 6
Benzinga Newsdesk - Nov 1, 2022, 5:24PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved